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The function of immunoglobulin  D  (IgD) in the immune response is not yet clear; 
antibody activity in this immunoglobulin  class has not been found as easily as in other 
classes  and, so far, efforts  to show a biological activity in IgD  such as complement 
activation or  reactivity with skin, mast cells,  or  neutrophiles have  given negative 
results (1, 2). By contrast IgD has been found to be present on the membrane of a 
variable proportion of peripheral blood lymphocytes in human adults  (3)  and,  re- 
cently, on a much higher percentage of newborn (cord)  blood lymphocytes (4). 
The investigations to be reported here were performed to study the possible 
association of  IgD  with  other  immunoglobulin classes  on  the  membrane of 
human lymphocytes and investigate whether IgD might be passively acquired 
as a  cytophilic molecule. Our results show that IgD is usually associated with 
immunoglobulin  M  (IgM)  on lymphocyte membranes and virtually eliminate 
the  possibility that  IgD  is  acquired by a  cytophilic process.  These  findings 
provide support for the concept that IgD is a lymphocyte receptor. 
Materials and Methods 
Antisera and Fluorochrome Conjugates.-- 
Anti-IgD: Two different antisera were used. One (R 39) was prepared by immunizing rab- 
bits with D-myeloma protein isolated from a single serum by preparative starch-block electro- 
phoresis. The animals received 5 mg of IgD emulsified in complete Freund's adjuvant sub- 
cutaneously and were boosted 1 mo later with 5 mg of the same protein in incomplete adjuvant; 
they were then bled a week later. The immunoglobulin G (IgG) fraction of the pooled rabbit 
antisera was isolated by DEAL-cellulose column chromatography  and was conjugated with 
fluorescein isothiocyanate  (FITC)  1 (Baltimore Biological Laboratories, Baltimore, Md.)  by 
dialysis (5). The resulting conjugate had a fluorescein to protein molar (F/P) ratio of 2.5. 
Another aliquot was conjugated with tetramethylrhodamine  isothiocyanate  (TRITC) with 
the procedure of Cebra and Goldstein (6) as modified by Amante et al. (7). The conjugates 
were then made specific by absorption; this was performed by adding to 20 ml of the conjugate 
(0.5 mg of protein/ml), a  mixture of 5 mg of IgG (Cohn fraction II, Mann Research Lab- 
oratories, New York), 2.5 mg of IgM prepared as indicated by Peruis et al. (8), and 1 ml of 
IgD-deficient serum. All the absorbents were insolubilized by ethyl chloroformiate (9)  and 
1  Abbreviations used in this paper: FITC, fluorescein isothiocyanate; TRITC, tetramethyl- 
rhodamine isothiocyanate. 
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were left in contact with the conjugate overnight at 4°C; the absorption was repeated twice. 
After absorption, the conjugates did not react with human IgG or IgM plasma cells obtained 
from the bone marrow from cases of multiple myeloma or Waldenstr6m's macroglobulinemia. 
On the other hand, they gave a faint but definitive  precipitin line when tested with a D-myeloma 
serum. 
The  other antiserum was prepared independently as indicated by Rowe et  al.  (4).  The 
absorbed goat antiserum was conjugated with FITC, as previously described, and with TRITC 
(7). The conjugates were further absorbed with IgM-coated polyacrylamide beads (10) using 
IgM prepared from a  case of Waldenstr6m's macroglobulinemia. Conjugates prepared from 
both antisera gave similar results. 
A nti-IgM: Again two different antisera were used. One was prepared by immunizing rabbits 
with IgM prepared from different cases of Waldenstr6m's macroglobulinemia as indicated 
above. The immunization procedure as well as the preparation of the conjugates were the 
same as for the anti-IgD serum R 39. The absorption of the conjugates was also performed in 
the same way, but 3 mg of insolubilized IgD (prepared from D-myeloma serum as indicated 
above) was substituted for the 2.5 mg of IgM in each absorption. The anti-IgM conjugates 
were tested for specificity on human plasma cells  from the bone marrow of IgG-myeloma 
patients, which did not stain, as well as in double staining with a specific anti-IgG on normal 
human spleen plasma cells,  which showed no doubly stained cells  except occasional double 
IgG and IgM producers. 
The second anti-IgM serum was prepared by immunization of sheep with the IgM isolated 
from two cases of Waldenstr6m's macroglobulinemia. Before conjugation, the antiserum was 
absorbed with glutaraldehyde-insolubilized human cord serum  (11) so as to be specific  for 
IgM by gel diffusion tests. Conjugation with FITC and TRITC was carried out as described 
for the second anti-IgG antiserum. The conjugates were further absorbed with a  mixture of 
insolubilized IgM-deficient serum and of two insolubilized D-myeloma protein preparations 
(11). As an additional check on the specificity of these conjugates, a mixture was prepared of 
TRITC-labeled  anti-IgD  and  FITC-labeled  anti-IgM.  Absorption  of  this  mixture  with 
insolubilized IgM removed the ability of the mixture to stain lymphocytes with fluorescein 
but  left  rhodamine unaffected. Absorption with insolubilized IgD  had  the  reverse effect: 
fluorescein  staining was unaltered; rhodamine staining became weak or absent. Conjugates 
prepared from both antisera gave similar results. 
Anti-K and anti-X: One anti-K and one anti-X were prepared, conjugated with fluorochrome, 
and checked for specificity by immunofluorescence as previously described (12). A  second 
pair consisting of a sheep anti-K and a rabbit anti-X were selected on the basis of their specificity 
and their reactivity both with free light chains and with intact immunoglobulins. In particular, 
the anti-X was shown to precipitate several D-myeloma proteins in immunoelectrophoresis. 
The anti-K was conjugated with fluorescein  and the anti-)~ with rhodamine as described above 
(4, 7). 
Anti-immunoglobulin was prepared by immunization of rabbits with human Cohn fraction 
II using the schedule described above for anti-IgD R  39. The antiserum was conjugated by 
the dialysis method (5). Before use, all conjugates were ultracentrifuged at  100,000 g for 60 
min to remove aggregates. 
Preparation  of  Lymphocytes,  Staining  for  Surface  Immunoglobulins,  and  Fluorescence 
Microscopy.--The procedure followed at Basle for human peripheral blood lymphocytes (from 
cord blood or from adult blood obtained by venepuncture) was essentially the same as that 
described by Pernis et al. (8). When double staining for IgD and IgM was performed, 0.05 ml 
of each conjugate (one rhodamine labeled and one fluorescein  labeled)  was mixed and added 
to 0.05 ml of the cell suspension (10-20  >(  10 e cells/ml). 
At Lausanne, lymphocytes were separated and stained as described previously (4).  The 
preparations were viewed using a  Zeiss Universal microscope (Carl Zeiss,  Inc., New York) 
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pieces.  The filter system permitted separate identification of fuorescence due to fluorescein 
and rhodamine. Cells  were usually viewed after fixation of smears but similar results were 
obtained on cells in suspension. Cytocentrifuged preparations showed up to 30% monocytes 
in some preparations. Removal of monocytes by treatment with carbonyl iron and magnets 
did not affect the results. Most experiments of double staining were performed using mixtures 
of conjugates, after it had been shown that sequential treatment with each conjugate separately 
gave the same results. Faint staining of large mononuclear cells was seen in some experiments 
in both laboratories; these cells were not counted as immunoglobulin-positive lymphocytes. 
Anti-Immunoglobulin-Induced  Redistribution  (Capping)  of  Surface  Immunoglobulins.-- 
Separate capping of IgD and IgM: In these experiments, the lymphocytes were stained first 
with anti-IgD or anti-IgM conjugated with fluorescein.  After staining, the cells were kept for 
30 rain at 37°C in Hanks' fluid with 10%  fetal calf serum to allow capping; they were then 
restained with a rhodamine conjugate either of the same antiserum used for capping or of an 
antiserum directed against the other immunoglobulin class. The second staining was under 
noncapping conditions, that is in the cold (4°C) and in the presence of 2 mM NAN3. Thus in a 
typical experiment, the lymphocytes were first treated with fluorescein-conjugated anti-IgD 
and allowed  to form green caps and then divided into two aliquots, one restained in "non- 
capping" conditions with rhodamine-conjugated anti-IgD  (a check for the completeness of 
IgD capping) and the other restained with rhodamine-conjugated anti-IgM. 
Capping by anti-light chain antiserum: The capping was induced as indicated above with 
nonconjugated anti-K and was followed by staining of the cells (under noncapping conditions) 
with a  mixture  of  anti-IgD  conjugated  with  rhodamine  and  anti-IgM  conjugated  with 
fluorescein. 
Capping and resynthesis: The capping was induced with a variety of fluorescein-conjugated 
antisera after the procedure indicated above; the cells  were then maintained for  14-20  h 
in tissue culture medium (RPMI) with 10% fetal calf serum at 37°C to allow the resynthesis 
of surface immunoglobulins (13). The newly synthesized immunoglobulins were detected by 
restaining with rhodamine-conjugated antisera. These experiments were carried  out  under 
sterile conditions. 
RESULTS 
The percentage of lymphocytes positive for IgD and IgM and the percentage 
staining for both classes are shown in Table I. Similar results were obtained 
using the different anti-IgD and anti-IgM conjugates prepared in both labora- 
tories. The mean value for IgD-positive cells in newborns was  14.6%  and in 
adults 5.3 %. A wide range of values was found in adults; repeated observations 
on the same individual showed that the values remained similar over a period of 
several months. 
Most of the cells carrying IgD also carried IgM and vice versa. After double 
staining of cells from adults with anti-IgD and anti-IgM conjugates, an average 
of 75 % of the IgD-positive cells were found to be IgM positive, and an average 
of 82 % of the IgM-positive cells were found to be IgD positive. Similar higher 
values were obtained for the lymphocytes of the newborn. As these percentages 
show, a minority of IgD-positive cells clearly lacked demonstrable IgM and a 
minority of IgM-positive cells lacked IgD.  There was  considerable variation 
among different lymphocytes in the brightness of their staining for IgD and for 
IgM, suggesting that individual positive cells differed in the amount of each of 
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TABLE I 
IgD and IgM on Peripheral  Blood Lymphocytes 
Individuals  IgD 
Percent positive cells* 
IgM  IgD-M,  +  IgM-D§ 
% 
Newborn  12  18  86  82 
"  12  9  86  91 
Adult Ro  7  (5-8,10)  6  (6-6,3)  91  (90-93,3)  93  (91-96,3) 
"  Hu  3  (2-4,5)  6  (5  7,5)  67  (55-80,2)  60  (55~5,2) 
"  Zi  11  (10-12,4)  7  74  93 
"  Pf  2  2  70  82 
Groups[[  Percent positive cells*[ 
Newborns**  14.6  (7-26,14)  13  (9-18,2)  86  (86-86,2)  86  (82-91,2) 
Adults  5.3  (2-17,12)  5.6  (2-7,5)  75.5  (67-91,4)  82  (60-93,4) 
* When the same individual was examined on different occasions, the range and the num- 
ber of examinations are indicated in parentheses. For IgD and IgM, at least 500 cells were 
usually counted. 
The percent of cells initially identified as IgD-positive cells that were found also to be 
IgM positive. At least 100 cells were counted. 
§ The percent of cells initially identified as IgM-positive cells that were found to be IgD 
positive. At least 100 cells were counted. 
II Including  the six individuals shown in this table. 
¶ Mean for the group, with range and number of individuals in parentheses. 
** Includes previously published values (4). 
in the intensity of staining with each fluorochrome, implying that the ratios of 
the amounts of each immunoglobulin  differed among cells. 
Further evidence that two  classes of immunoglobulins were present on the 
membrane of the same cell was obtained from experiments involving  independ- 
ent capping. Lymphocytes incubated with fluorescein-conjugated anti-IgD at 
0°C and in the presence of  sodium azide  showed fuorescence distributed in a 
granular pattern over the entire cell membrane. After incubation of these cells 
at 37°C for 30 rain in the absence of azide, fluorescence was usually in the form 
of a  cap at one pole of the cell, as described previously by Taylor et al. (14). 
To assess independent capping of the two classes, cells of two newborns were 
incubated with fluorescein-labeled anti-IgD under capping conditions and then 
exposed  to  rhodamine-labeled anti-IgM. Cells usually showed  a  green cap of 
fluorescence and a diffuse red granular staining due to rhodamine. Thus capping 
of IgD induced by the anti-IgD conjugate did not induce capping of IgM. If 
rhodamine-labeled anti-IgD were substituted for the rhodamine-labeled anti- 
IgM,  the same cap showed both green and red fluorescence with no staining 
outside the cap. Similarly independent capping was also observed if the initial 
conjugate  used  for  capping  was  fluorescein-labeled anti-IgM.  In  this  case, 
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staining with rhodamine-labeled anti-IgM gave caps with both green and red 
fluorescence and no diffuse staining. 
In view of the presence of two heavy chain classes on the same cell, experi- 
ments were carried out to investigate whether both types of light chains could 
also be detected. When  cells were exposed to a  mixture of fluorescein-labeled 
anti-K and rhodamine-labeled anti-X, no double staining was seen in accordance 
with previous findings (15). In further experiments, cells were exposed to mix- 
tures  of  conjugates  of  anti-IgD  and  anti-light  chain  labeled  with  different 
fluorochromes  (Table  II).  Of  the  IgD-positive cells,  an  average  of  55%  ap- 
peared positive for  K and 41%  positive for X. 
TABLE II 
IgD, K, and X on Peripheral  Blood Lymphocytes 
Percent positive cells* 
Individuals 
X  IgD-K$  IgD-X§ 
% 
Ro  12  (5-18,3)  6  (3-9,3)  50  (47-54,2)  42  (39-46,2) 
Zi  11  (6-16,2)  13  (10-16,2)  52  (50-54,2)  46  (44-48,2) 
Hu  7  2  67  35 
Pf  5  1  69  32 
To  8  6  48  50 
Newborn  6  7  45  38 
"  3  4  55  43 
Mean  7.4  5.6  55  41 
* See footnote * of Table I. For K and ~, 500 cells were usually counted. For IgD-K and 
IgD-X,  100 positive cells were counted. 
:~ The percent of cells initially identified  as IgD positive that were found also  to  be K- 
positive. 
§ The percent of cells initially identified  as IgD positive that were found to be also  X- 
positive. 
Ceils  were  also  exposed  to  unlabeled  anti-K  under  capping  conditions. 
Subsequent  exposure  to  a  mixture  of  rhodamine-labeled  anti-IgD  and fluo- 
rescein-labeled anti-IgM showed capping of some cells. If capping was present, 
it was coincident and complete for both immunoglobulin classes. These findings 
showed that the IgD of one cell was of one light chain type only (with  a  slight 
preponderance of IgD-K cells) and  that  the light chain  type of  IgD and IgM 
on the same cell was identical. They also indicated that light chains, of either 
K- or X-type, could almost invariably be detected on IgD-positive cells. Finally, 
they provided direct evidence that the molecule stained by the anti-IgD was in 
fact immunoglobulin since it could be capped by anti-K chain antiserum. 
It has been previously observed that after exposure of lymphocytes to anti- 
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appearance  of fluorescence due  to  endocytosis or  shedding.  After prolonged 
incubation, reexposure to fluorescent conjugate demonstrates a  diffuse distri- 
bution of resynthesized immunoglobulin  on  the  cell  membrane (13).  Similar 
findings were obtained for IgD. Lymphocytes of cord blood selected to show a 
high  percentage  of  IgD-positive  cells  were  tested.  Exposure  to  fluorescein- 
conjugated  anti-IgD  or anti-immunoglobulin  and  incubation  resulted in  the 
formation of green caps  within  1 h,  as described previously. When the  cells 
were restained with rhodamine-conjugated anti-IgD after 16-20 h  incubation, 
a proportion of cells showed rhodamine staining in a diffuse distribution, but no 
cells showed any residual fluorescein stain.  Thus  there was evidence of reap- 
pearance of IgD on the membrane. Under similar conditions, IgM reappeared 
more rapidly; in one experiment, the number of IgM-positive cells  was fully 
restored after 14 h incubation. 
DISCUSSION 
The high proportion of human peripheral blood lymphocytes carrying IgD 
on their membrane is in striking contrast with the very low concentration of 
IgD  in  the  serum.  The most extreme case is  seen in  cord blood where very 
many B  lymphocytes have  membrane IgD,  whereas  IgD  cannot usually be 
detected, even by highly sensitive methods, in the serum (4). Even in adults, 
the  percentage  of IgD-carrying lymphocytes,  although  variable  in  different 
individuals,  is  always  high  in  proportion  to  the  IgD  concentration  on  the 
serum (3). 
Before considering the possible biological implications of these findings, two 
possibilities require elimination: (a) that reaction of human lymphocytes with 
anti-IgD  antisera  may have  been  due  to  cross-reactivity of the  conjugated 
antisera  with  nonimmunoglobulin components of the  lymphocyte membrane 
or with other immunoglobulin classes  (notably IgM). This is ruled out by the 
following: (i) Anti-immunoglobulin and anti-light chain antisera capped all the 
determinants reacting  with  anti-IgD;  this  eliminates  the possibility that  the 
anti-IgD reacted with nonimmunoglobulin components of the cell membrane. 
(ii)  There was  independent movement of IgD  and  IgM  on  the  lymphocyte 
membrane. Thus the staining given by the anti-IgD could not be due to some 
form of reactivity with IgM,  since molecules reactive with  anti-IgD  did not 
react with anti-IgM and vice versa. (b) That IgD is not an active product of 
the lymphocytes that carry" it but rather that it is passively absorbed by the 
cells as a  cytophilic molecule. This possibility is also ruled out by two facts: 
(i) that cells from which IgD has been removed by exposure to antisera showed 
reappearance of IgD on their membrane during incubation in IgD-free medium; 
(ii)  that lymphocytes that carry IgD  (and IgM)  carry only one type of light 
chain, i.e., either K or X. Passively adsorbed IgD would not be expected to be 
of one light  chain type only, nor restricted  to the same light  chain  type as 
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not  only by  double  staining  of  the  lymphocytes with  anti-IgD  and  anti-K 
or anti-X,  but  also by showing that  after treatment with  anti-g antiserum a 
proportion of IgD-positive  cells  showed  complete capping  both  of IgD  and 
IgM. We therefore conclude that the IgD of the lymphocyte membrane is the 
active product of the cell that carries it and that IgD fulfills in this respect an 
obligatory requirement for a lymphocyte antigen receptor. 
In  the light of these findings, we propose the hypothesis that  the thus far 
elusive biological function of IgD is that of an antigen receptor on the lympho- 
cyte membrane. Other known features of IgD  are consistent with  this view. 
IgD is secreted only in  small amounts and by very rare plasma cells (12), in 
striking contrast with the high proportion of lymphocytes having IgD on their 
membrane. The biological properties important for the effector roles of secreted 
immunoglobulins, such as complement activation, skin  fixation, concentration 
in secretions, and placental transfer, have not been found in the IgD class (4). 
The finding that  both IgD  and IgM  are  simultaneously present  in  a  high 
proportion of lymphocytes is remarkable and does not follow the pattern  of 
previous  reports  concerning other immunoglobulins  where restriction to one 
class is the general rule  (16). We consider three possible implications of this 
finding: (a) The combining sites of IgD and IgM receptors differ. This would 
probably  require  the  same  cell  simultaneously  to  express  two  different V~ 
region genes and to link their products separately to those of two different C~ 
region genes.  We regard  this  as  unlikely. It  seems  more probable  that  both 
receptors have the same combining site,  consistant with the presence of light 
chains of one type only. (b) The class of the receptor determines the signal to 
the cell. For example, tolerance and induction may be dependent on the heavy 
chain class of the receptor. (c) IgD constitutes the first antigen receptor. The 
appearance  of  IgM  (potentially  a  secreted  immunoglobulin)  as  a  receptor 
indicates a  step in differentiation towards  a  plasma  cell.  Thus  one  cell  line 
may shift synthesis from one heavy chain class to another, the sequence being 
---> # ~  3, with ~ and # showing overlap. We favor explanations based on the 
second and  the  third possibilities,  which  are not in  themselves mutually ex- 
clusive. In any event, we consider that the simultaneous presence of two recep- 
tors  on  the  same  cell  indicates  a  remarkable  genetic  event  of fundamental 
significance for immune responsiveness. 
SUMMARY 
A  large  proportion  of the  human  peripheral  blood lymphocytes of adults 
and newborns having IgD  were found also to have IgM on their membranes 
and vice versa. A few lymphocytes had one of these classes only. IgD and IgM 
could be capped independently on the same cell. The possibility that IgD was 
acquired by a cytophilic process was excluded by the finding that IgD-bearing 
cells were of one light chain type only, and by the direct demonstration of re- 
appearance of IgD on the lymphocyte membrane during incubation in an IgD- 972  IMMUNOGLOBULIN D  AS  A  LYMPHOCYTE  RECEPTOR 
free  culture  medium.  On  the  basis  of these  findings,  it  is  proposed  that  IgD 
functions as a  lymphocyte antigen  receptor. 
We thank Professors P. Vassalli and J.-P. Lamellin for the use of their fluorescence micro- 
scope for some of these  experiments. 
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